SCHEMBL24209986

SCHEMBL24209986

CC1(C)c2ccccc2N(P(=S)(c2ccccc2)N2c3ccccc3C(C)(C)c3ccccc32)c2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 7/20 0.39
▸ HTT P42858 6/20 0.39
▸ KMT2A Q03164 7/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ MAPT P10636 9/20 0.38
▸ MEN1 O00255 6/20 0.38
▸ THRB P10828 4/20 0.38
▸ RECQL P46063 4/20 0.38
▸ GAA P10253 4/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ ALDH1A1 P00352 4/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ POLB P06746 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ APOBEC3A P31941 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23911738 0.84 LMNA (0.41) LMNAHTTKMT2ACYP2D6CYP1A2
SCHEMBL23911740 0.81 LMNA (0.33) LMNAKMT2AMAPTMEN1GAA
SCHEMBL23911725 0.79 MAPT (0.41) LMNAHTTKMT2ACYP2D6CYP1A2
SCHEMBL23911739 0.78 HTR2A (0.38) LMNAHTTKMT2ACYP2D6CYP1A2
SCHEMBL23911734 0.76 LMNA (0.40) LMNAHTTKMT2ACYP2D6CYP1A2
SCHEMBL23911696 0.69 LMNA (0.43) LMNAHTTKMT2AMAPTMEN1
SCHEMBL23911733 0.68 LMNA (0.44) LMNAHTTKMT2AMAPTMEN1
SCHEMBL13231539 0.68 KMT2A (0.47) LMNAHTTKMT2ACYP2D6CYP1A2
SCHEMBL280367 0.68 HTT (0.58) LMNAHTTKMT2ACYP2D6CYP1A2
SCHEMBL29438184 0.68 HTT (0.58) LMNAHTTKMT2ACYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220020937-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220020937-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TRPC1, ODC1, DDT LMNA 810/4885HTT 511/4885KMT2A 1577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback